Cagrilintide

Cagrilintide is a long-acting synthetic analog of human amylin, engineered through lipidation and amino acid substitutions to enhance stability and resistance to enzymatic degradation. As an amylin receptor agonist, it is structurally designed to activate amylin-mediated signaling pathways with extended half-life properties, making it a compound of interest in metabolic and endocrine research.
In laboratory studies, Cagrilintide is investigated for its role in modulating amylin receptor activity and its potential influence on satiety signaling, gastric emptying, and glucose homeostasis pathways. It has also been explored in combination research with GLP-1 receptor agonists to study synergistic effects on energy regulation and metabolic signaling under varying experimental conditions. Because of its extended stability profile and defined sequence, it serves as a reliable peptide for ongoing research into amylin receptor pharmacology, peptide half-life optimization, and metabolic pathway interactions.
Note: For research use only. Not for human consumption.